Cargando…
PDCD5 transfection increases cisplatin sensitivity and decreases invasion in hepatic cancer cells
Low expression levels of the programmed cell death 5 (PDCD5) gene have been reported in numerous human cancers, however, PDCD5 expression has not been investigated in hepatic cancer. The present study aims to investigate the biological behavior of PDCD5 overexpression in hepatocellular carcinoma (HC...
Autores principales: | FAN, GUI-LING, YAO, YONG, YAO, LI, LI, YUN |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4246700/ https://www.ncbi.nlm.nih.gov/pubmed/25436001 http://dx.doi.org/10.3892/ol.2014.2645 |
Ejemplares similares
-
microRNA-106a modulates cisplatin sensitivity by targeting PDCD4 in human ovarian cancer cells
por: LI, HAO, et al.
Publicado: (2014) -
miR-150 Modulates Cisplatin Chemosensitivity and Invasiveness of Muscle-Invasive Bladder Cancer Cells via Targeting PDCD4 In Vitro
por: Lei, Ye, et al.
Publicado: (2014) -
Androgen receptor suppresses lung cancer invasion and increases cisplatin response via decreasing TPD52 expression
por: Liu, Shiqing, et al.
Publicado: (2023) -
Anti-Inflammatory Effects of Recombinant Human PDCD5 (rhPDCD5) in a Rat Collagen-Induced Model of Arthritis
por: Xiao, Juan, et al.
Publicado: (2014) -
Recombinant human PDCD5 (rhPDCD5) protein is protective in a mouse model of multiple sclerosis
por: Xiao, Juan, et al.
Publicado: (2015)